Analysis of Fluid Flow through the Grinding Zone

A theoretical model of fluid flow in grinding has been developed by an analysis of fluid flow through a porous medium. Fluid tangential velocity, radial velocity, depth of penetration into the wheel, and the useful flow rate through the grinding zone are predicted by using this model. The analysis indicates that the nozzle position, nozzle velocity (or flow rate), and the effective wheel porosity are the three main factors which most significantly influence the useful flow rate through the grinding zone. A dimensionless effective wheel porosity parameter is introduced which is the ratio of the effective wheel porosity to its bulk porosity. By fitting the theoretical analysis to available experimental results, creep feed wheels were found to have much bigger dimensionless effective porosities than conventional wheels, which enhances their ability to more effectively pump fluid through the grinding zone.

Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension

OBJECTIVES

This study compared clinic and ambulatory blood pressure measurement and the reproducibility of these measurements in older patients with isolated systolic hypertension (ISH).

PATIENTS

Eighty-seven patients aged greater than or equal to 60 years with ISH on clinic measurement were followed in the placebo run-in phase of the Syst-Eur trial.

METHODS

Clinic blood pressure was defined as the mean of two blood pressure readings on each of three clinic visits (six readings in total). Ambulatory blood pressure was measured over 24 h using non-invasive ambulatory blood pressure monitors.

RESULTS

Daytime ambulatory systolic pressure was, on average, 21 mmHg lower than the clinic blood pressure, whereas diastolic pressure was, on average, similar with both techniques of measurement. In the 42 patients who had repeat measurements, clinic blood pressure levels nad the amplitude of the diurnal blood pressure profile (fitted by Fourier analysis) were equally reproducible. However, both were less reproducible than ambulatory blood pressure levels. The repeatability coefficients, expressed as per cent of near maximum variation (four times the standard deviation of a given measurement), were 52% and 45% for the clinic systolic and diastolic pressures, 56% and 42% for the amplitude of the diurnal profile, and 29% and 26% for mean 24-h pressures.

CONCLUSIONS

In older patients with ISH, clinic and ambulatory systolic blood pressure measurements may differ largely: the prognostic significance of this difference remains to be elucidated. Furthermore, in these patients the level of pressure is more reproducible by daytime ambulatory blood pressure measurement than by clinic measurement.

[Pharmacological study on Cordyceps sinensis (Berk.) Sacc. and ze-e Cordyceps]

The Ze-e Cordyceps is similar to the Cordyceps sinensis in such pharmacological actions as calming, enduring hypoxia, dilating trachea, male sex hormone action, antiphlogistic and toxicity, etc. It is thus suggested that the Ze-e Cordyceps may be used place of the Cordyceps sinensis in clinical practice.

Trials in elderly patients with isolated systolic hypertension

The hypothesis that antihypertensive drugs should be prescribed to elderly patients with isolated systolic hypertension is being addressed in at least 3 trials: the Systolic Hypertension in the Elderly Program (SHEP) in the United States, a trial in China, and the Syst-Eur study in Europe. The SHEP trial has recently reported its final morbidity and mortality results. This article summarizes the protocol of the European study. To be eligible for the Syst-Eur trial, patients must be at least 60 years old and have a systolic blood pressure averaging 160-219 mmHg with a diastolic pressure less than 95 mmHg. Patients must give their informed consent and be free of major cardiovascular and non-cardiovascular diseases at entry. The patients are randomized into active treatment or placebo. Active treatment consists of nitrendipine (10-40 mg/d), combined with enalapril (5-20 mg/d) and hydrochlorothiazide (12.5-25 mg/d), as necessary. The control group received matching placebos. The drugs (or matching placebos) are stepwise titrated and combined in order to reduce systolic blood pressure by 20 mmHg at least to a level below 150 mmHg. Morbidity and mortality are monitored to enable an intention-to-treat and per protocol comparison of the outcome in the two treatment groups.

Mean and range of the ambulatory pressure in normotensive subjects

To perform a meta-analysis of published reports in an attempt to determine the mean and range of normal ambulatory blood pressure (BP), 23 studies including a total of 3,476 normal subjects were reviewed. Most studies were compatible with a mean 24-h BP in the range of 115-120/70-75 mmHg, a mean day time BP of 120-125/75-80 mmHg, and a mean night time BP of 105 to 110/60 to 65 mmHg. With weighting for the number of subjects included in the individual studies, the 24-h BP averaged 118/72 mmHg, the day time BP 123/76 mmHg, and the night time BP 106/64 mmHg. The night/day pressure ratio averaged 0.87 for systolic and 0.83 for diastolic BP, with ranges across the individual studies from 0.79 to 0.92 and from 0.75 to 0.90, respectively. If the mean +/- 2 standard deviation interval in the various studies was considered normal, the range of normality was on average 97 to 139/57 to 87 mmHg for the 24-h BP, 101 to 146/61 to 91 mmHg for the day time BP, and 86 to 127/48 to 79 mmHg for the night time BP. Until the results of prospective studies on the relation between the ambulatory BP and the incidence of cardiovascular morbidity and mortality become available, the aforementioned intervals, which summarize the experience of 23 investigators, could serve as a temporary reference for clinical practice.

Twenty-four hour blood pressure monitoring in the Syst-Eur trial

This article describes the objectives and protocol of a study on ambulatory blood pressure in elderly patients with isolated systolic hypertension. This study constitutes an optional side-project to the Syst-Eur trial. The multicentre Syst-Eur trial investigates whether antihypertensive treatment of elderly patients with isolated systolic hypertension will influence the incidence of stroke. Secondary endpoints include cardiovascular events, such as myocardial infarction. The main objective of the side-project is to investigate whether ambulatory blood pressure monitoring will improve the prediction of cardiovascular complications based on blood pressure measurement in the clinic. The side-project also provides the opportunity to evaluate the diurnal profile of blood pressure in elderly patients with isolated systolic hypertension randomized to placebo or active antihypertensive treatment.

Experimental Measurement of Fluid Flow Through the Grinding Zone

An experimental test rig was developed to measure the amount of grinding fluid which flows through the grinding zone in straight plunge grinding. Proportional relationships were generally obtained between the flow rate from the nozzle and the useful flow rate of fluid passing through the grinding zone. The percentage of applied fluid passing through the grinding zone was found to depend mainly on the bulk porosity of the grinding wheel and the nozzle position. Wheel dressing has only a secondary influence, which is attributed to its influence on the surface porosity of the wheel. The workspeed and wheel depth of cut have virtually no influence.

[Quantitative analysis of semen Cuscutae]

In this paper, the quantitative analysis of the total flavone in 7 species revealed the contents: Semen Cuscutae Chinensis (3.0%), Semen Cuscutae Australis (3.2%) as compared with Semen Cuscutae Europaea (4.5%). Semen Cuscutae Chinensis has the highest content of polysaccharide of about 5-6%. The experimental results provide a scientific basis the rational use of Semen Cuscutae.

[Rational close planting in raising the seedlings of Panax quinguefolium linn]

It has been found that the effect of planting density is hardly noticeable for one-year-old seedlings, but very apparent for 2-year-old ones. With the increase of planting density, the leaf area gets smaller, stem higher, and root thinner and shorter. The larger the planting density. The smaller the dry weights of canopy and root and the root-canopy ratio. It is thus advocated that rational planting densities be selected according to the proper cultivation systems.

Isolated systolic hypertension in the elderly: an epidemiologic review

Isolated systolic hypertension (ISH) is usually defined as a systolic blood pressure greater than or equal to 160 mm Hg and diastolic blood pressure less than 90 or 95 mm Hg. Systolic blood pressure has been found to increase with age in most populations studied and thus the prevalence of ISH can be expected to increase with age. ISH is more prevalent in elderly women than in elderly men. Estimates of the prevalence of ISH vary according to its definition and the number of blood pressure measurements. There is evidence that the prevalence of ISH is decreasing. Results of a survey of the prevalence of ISH in 11 countries are presented; the estimates among men aged 60 to 69 years ranged from 1% in Israel to 24% in Norway. Only a prospective standardized survey conducted in several countries will reveal the true prevalence of ISH.

[Studies of the herbal and botanical origins of seman Cuscutae]

Herbalogical study shows that Seman Cuscutae originated from Cuscuta chinensis is one of the most commonly used drugs in ancient times. Survey of botanical origins indicates that there are 9 species in Genus Cuscutae and 4 of them are commodities. The Cuscuta chinensis specified in current Chinese Pharmacopoeia (1985) is not the principal one.

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III)

Human T-lymphotropic virus type III (HTLV-III) encodes a trans-acting factor that activates the expression of genes linked to the HTLV-III long terminal repeat. By functional mapping of complementary DNA transcripts of viral messenger RNA's the major functional domain of the gene encoding this factor was localized to a region immediately before the env gene of the virus, a region previously thought to be noncoding. This newly identified gene consists of three exons, and its transcription into messenger RNA involves two splicing events bringing together sequences from the 5' part (287 base pairs), middle (268 base pairs), and 3'part (1258 base pairs) of the HTLV-III genome. A similar messenger RNA with a truncated second exon (70 base pairs) does not encode a trans-acting function. It is proposed that this second messenger RNA is the transcript of a gene (3'-orf) located after the env gene. Messenger RNA's were also identified for the env and gag-pol genes of HTLV-III.

Human-proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus

The nucleotide sequences of the six regions within the normal human cellular locus (c-sis) that correspond to the entire transforming region of the simian sarcoma virus (SSV) genome (v-sis) were determined. The regions are bounded by acceptor and donor splice sites and, except for region 6, resemble exons. Region 6 lacks a 3' donor splice site and terminates -5 base pairs from the 3' v-sis-helper-viral junction. This is consistent with a model proposing that SSV was generated by recombination between proviral DNA of a simian sarcoma associated virus and proto-sis and that introns were spliced out subsequently from a fused viral-sis messenger RNA. This also suggests that the 3' recombination occurred within an exon of the woolly monkey (Lagothrix) genome. The open reading frames predicting the v-sis and c-sis gene products coincide with the stop codon of c-sis located 123 nucleotides into the fifth region of homology. The overall nucleotide homology was 91 percent with substitutions mainly in the third codon positions within the open reading frame and with greatest divergence within the untranslated 3' portion of the sequences. The predicted protein products for v-sis and c-sis are 93 percent homologous. The predicted c-sis gene product is identical in 31 of 31 amino acids to one of the published sequences of platelet-derived growth factor. Thus, c-sis encodes one chain of human platelet-derived growth factor.